Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| 1 |
MON
Monsanto Co
MON
|
$1.03B |
| 2 |
Cisco
CSCO
|
$872M |
| 3 |
Alibaba
BABA
|
$721M |
| 4 |
AbbVie
ABBV
|
$560M |
| 5 |
Ventas
VTR
|
$540M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$1.65B |
| 2 |
Biogen
BIIB
|
$907M |
| 3 |
Yum! Brands
YUM
|
$897M |
| 4 |
Oracle
ORCL
|
$778M |
| 5 |
BHI
Baker Hughes
BHI
|
$557M |
Sector Composition
| 1 | Healthcare | 21.41% |
| 2 | Technology | 12.87% |
| 3 | Industrials | 11.05% |
| 4 | Communication Services | 10.38% |
| 5 | Consumer Staples | 8.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
KLA
KLAC
$115B
| $928M | 0.32% | 11,780,550 -500,000 | -4% | -$39.4M |
|
77
TechnipFMC
FTI
$15.1B
| $911M | 0.32% | 16,778,922 +1,034,000 | +7% | +$56.2M |
|
78
Motorola Solutions
MSI
$78.7B
| $892M | 0.31% | 14,097,115 -4,441,478 | -24% | -$281M |
|
79
JPMorgan Chase
JPM
$829B
| $865M | 0.3% | 14,351,525 -1,054,260 | -7% | -$63.5M |
|
|
80
Ventas
VTR
$30.9B
| $860M | 0.3% | 13,883,291 +8,715,291 | +169% | +$540M |
|
81
ConocoPhillips
COP
$124B
| $851M | 0.29% | 11,115,100 -2,250,000 | -17% | -$172M |
|
|
EMC
82
DELISTED
EMC CORPORATION
EMC
| $845M | 0.29% | 28,869,000 +650,000 | +2% | +$19M |
|
83
Progressive
PGR
$145B
| $844M | 0.29% | 33,386,155 -3,880,000 | -10% | -$98.1M |
|
84
CME Group
CME
$96B
| $836M | 0.29% | 10,456,500 +4,956,500 | +90% | +$396M |
|
85
Mondelez International
MDLZ
$79.5B
| $827M | 0.29% | 24,130,400 | – | – |
|
86
Exxon Mobil
XOM
$487B
| $822M | 0.28% | 8,742,300 -229,000 | -3% | -$21.5M |
|
87
Hologic
HOLX
$14.9B
| $818M | 0.28% | 33,607,145 | – | – |
|
88
PepsiCo
PEP
$204B
| $811M | 0.28% | 8,716,188 | – | – |
|
89
Caterpillar
CAT
$196B
| $799M | 0.28% | 8,069,033 +248,200 | +3% | +$24.6M |
|
90
T-Mobile US
TMUS
$284B
| $785M | 0.27% | 27,190,960 -8,975,421 | -25% | -$259M |
|
91
NRG Energy
NRG
$28.2B
| $784M | 0.27% | 25,717,077 -12,057,470 | -32% | -$368M |
|
92
Darden Restaurants
DRI
$24.1B
| $784M | 0.27% | 15,225,500 -473,939 | -3% | -$24.4M |
|
|
MJN
93
DELISTED
Mead Johnson Nutrition Company
MJN
| $781M | 0.27% | 8,114,686 -423,155 | -5% | -$40.7M |
|
94
Duke Energy
DUK
$95.3B
| $751M | 0.26% | 10,044,334 +4,725,000 | +89% | +$353M |
|
95
APA Corp
APA
$8.31B
| $743M | 0.26% | 7,912,900 | – | – |
|
96
Danaher
DHR
$147B
| $742M | 0.26% | 9,764,348 -1,654,339 | -14% | -$126M |
|
97
Procter & Gamble
PG
$368B
| $739M | 0.26% | 8,819,000 +450,000 | +5% | +$37.7M |
|
|
98
Alibaba
BABA
$322B
| $721M | 0.25% | +8,115,335 | New | +$721M |
|
|
AET
99
DELISTED
Aetna Inc
AET
| $711M | 0.25% | 8,774,500 -2,680,927 | -23% | -$217M |
|
|
TFCFA
100
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $707M | 0.24% | 20,605,800 -9,921,483 | -33% | -$340M |
|